β Blockers should be used more widely after myocardial infarctionBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7158.558 (Published 29 August 1998) Cite this as: BMJ 1998;317:558
- Alex Brooks
Many more patients would survive a myocardial infarction if β adrenergic blockers were used more widely, according to American researchers.
Stephen Gottlieb and colleagues from the University of Maryland reviewed 201752 records of patients who had had a myocardial infarction, 34% of whom were prescribed β blockers (New England Journal of Medicine1998;339:489-97).
As expected, patients in the study with known contraindications were less likely to be given β blockers–for example, very elderly people or those who have low ventricular ejection …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial